AU Patent

AU2019203244B2 — Syringe devices

Assigned to DMK Pharmaceuticals Corp · Expires 2020-04-02 · 6y expired

What this patent protects

Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly …

USPTO Abstract

Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger. Methods of assembling and using the syringe devices are also described. 1/10 100 250 108 1122 116 10 126 FIG. 1 114 106 1202

Drugs covered by this patent

Patent Metadata

Patent number
AU2019203244B2
Jurisdiction
AU
Classification
—
Expires
2020-04-02
Drug substance claim
No
Drug product claim
No
Assignee
DMK Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.